It is a virus that affects the liver and is known as hepatitis. The liver is a member of the body. The complex is composed of a large, sublime hybrids, which are under the right rib and perform important functions, purify the body, get rid of toxic substances, harmful substances, manufacture and work vital biological substances that help the body to perform its vital functions. Body.
C virus is a silent disease that destroys the liver and its collapse causes the C virus to cause hepatitis
• The C virus enters the cells and uses the cell’s genetic makeup to make copies of it that attack other cells.
• In 15% of cases, the inflammation is severe inflammation in the sense that the body can get rid of it automatically without any consequences in the long term. But in most cases (85%), inflammation is chronic and the body does not get rid of the virus.
• In most cases, the virus does not cause advanced liver disease even in the long run. However, in a few patients chronic hepatitis is active and the liver is slowly destroyed over many years. Thus, over time, chronic inflammation can lead to liver fibrosis and hepatic failure. In some cases of advanced cirrhosis, liver cancer may occur.
• In Egypt, many people suffer from C virus, and in some cases chronic hepatitis C, making it one of the most common diseases
In the framework of the future map for the treatment of hepatitis C, the World Conference on Gastroenterology in the United States recently addressed alternative treatments for C virus, including the addition of protease inhibitors to interferon injections and ribavirin tablets for the treatment of C virus, Which helps to increase the response rate of treatment to 70%.
Dr. Mohsen Maher, head of the Department of Internal Medicine at Ain Shams University, pointed to the possibility of developing the method of treatment and make it tablets only without the need to inject interferon. To improve the rate of sustained response to treatment as well as reduce the duration of treatment and its side effects, making it the best choice for doctors and patients.
These drugs prevent the spread of the virus inside liver cells, targeting other elements in the life cycle of the virus. NewNS4 / 3Aproteaseinhibitors, as well as RNA inhibitors that target RNA, are currently undergoing clinical trials and are in the final stages of clinical development and are expected to be marketed next year.
“We are still one of the world’s most prevalent countries with hepatitis C, where the incidence is 20 percent in some areas,” Dr. Mohsen Maher said. Due to the collective treatment of schistosomiasis in the 1960s and 1970s. Only 10 to 30 percent of HIV-positive patients could be cured without treatment, while the rest would be carriers, whether they had the disease or not. The infection is often not accompanied by any symptoms, but once infected, the patient has chronic hepatitis and may develop the condition to cirrhosis or liver cancer. The high rates of C virus transmission are due to the social behavior of the representative in the sharing of personal and private tools. Explaining that the virus is not transmitted through breastfeeding, sneezing, coughing and sharing utensils of eating or drinking, as some believe.
Interferon injections with ribavirin tablets are the optimal method for treatment of chronic hepatitis C virus, giving response rates of 40 to 50%